UA has significant anticancer activity and, together with the Cas9/sg-PD-L1 ribonucleoprotein complex (RNP) and a permeabilizing peptide (low molecular weight fisetin, LMWP), forms nanodrugs by self-assembly for the therapeutic approach to HCC. Here, CD274 is linked to hepatocellular carcinoma.